跳至主要内容
临床试验/IRCT20231125060174N1
IRCT20231125060174N1尚未招募1 期

Effect of Curcumin in the prevention of Peri-procedural Myocardial Injury following Percutaneous Coronary Intervention (PPMI)

Zahedan University of Medical Sciences0 个研究点目标入组 108 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
108

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Patients with ischemic heart disease and candidates for PCI or acute coronary syndrome who referred for coronary angiography with a possible clinical indication for PCI
  • Patients with acute coronary syndrome and candidates for PCI
  • Patients have undergone elective and non-emergency PCI
  • Consent to participate in the present study

排除标准

  • using the oral steroid drugs or NSAIDs except aspirin
  • Active malignancy or infection
  • History of Myelodysplasia
  • Severe Hepatic dysfunction (AST or ALT more than 3 times UMN)
  • Renal dysfunction (serum creatinine more than 2.5 mg/dL or undergoing dialysis)
  • History of revascularization (PCI or CABG)

研究者

发起方
Zahedan University of Medical Sciences

相似试验